日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen Exposure

空间分析揭示了小鼠肺腺癌前病变在致癌物暴露与否下的分子和免疫演变差异

Zhu, Bo; Aminu, Muhammad; Chen, Pingjun; Li, Jian-Rong; Dong, Chuanpeng; Li, Chenyang; Tian, Yanhua; Lu, Shao-Wei; Chen, Hong; Ma, Chenxi; Hu, Xin; Ye, Jie; Liu, Andrew Y; Huang, Beibei; Rojas, Frank R; Roger, Parra Cuentas Edwin; Shi, Ou; Nilsson, Monique B; Poteete, Alissa; Khan, Khaja B; Lu, Wei; Solis Soto, Luisa M; Fujimoto, Junya; Haymaker, Cara; Wistuba, Ignacio I; Wei, Zhubo; Wang, Linghua; Gibbons, Don L; Chen, Ken; Reuben, Alexandre; Schenkel, Jason M; Heymach, John V; Cheng, Chao; Wu, Jia; Zhang, Jianjun

Osimertinib activates a TGF-β2-dependent secretory program that drives lung adenocarcinoma progression.

奥希替尼激活TGF-β2依赖性分泌程序,从而驱动肺腺癌进展。

Ghosh Madhurima, Wu Chao, Kumar Abhishek, Nilsson Monique, Heymach John V, Zhao Weina, Yu Jiang, Liu Xin, Ding Na, Wang Shike, Xiao Guan-Yu, Chen Angelo, Grimley Kate, Russell William K, Creighton Chad J, Tan Xiaochao, Kurie Jonathan M

CoCo-ST detects global and local biological structures in spatial transcriptomics datasets

CoCo-ST能够检测空间转录组数据集中的全局和局部生物结构。

Aminu, Muhammad; Zhu, Bo; Vokes, Natalie; Chen, Hong; Hong, Lingzhi; Li, Jianrong; Fujimoto, Junya; Chaib, Mehdi; Yang, Yuqiu; Wang, Bo; Poteete, Alissa; Nilsson, Monique B; Le, Xiuning; Cascone, Tina; Jaffray, David; Navin, Nicholas; Wang, Tao; Byers, Lauren A; Gibbons, Don L; Heymach, John; Chen, Ken; Cheng, Chao; Zhang, Jianjun; Wu, Jia

Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

波齐替尼治疗EGFR 20号外显子插入突变型非小细胞肺癌:II期ZENITH试验的临床疗效及EGFR 20号外显子插入位置对药物敏感性的差异性影响

Le, Xiuning; Robichaux, Jacqulyne P; Nilsson, Monique; Vijayan, R S K; Ravichandran, Ashwin; Wu, Jia; Elamin, Yasir Y; Hong, Lingzhi; Pei, Jun; He, Jun; Patel, Sonia; Udagawa, Hibiki; Mani, Sriramvignesh; Jang, Chang Woon; Clarke, Jeffrey M; Tchekmedyian, Nishan; Goldman, Jonathan W; Socinski, Mark; Bhat, Gajanan; Leu, Sharon; Bunn, Veronica; Su, Zhenqiang; Vincent, Sylvie; Lawson, John W; Cross, Jason B; Heymach, John V

The Activity of EGFR CAR NK and CAR T Cells against EGFR Inhibitor-Resistant NSCLC and Drug-Tolerant Persister Cells.

EGFR CAR NK 和 CAR T 细胞对 EGFR 抑制剂耐药性 NSCLC 和耐药性持续细胞的活性。

Yang Yan, Nilsson Monique B, Yu Xiaoxing, Poteete Alissa, Jiang Hong, Huang Qian, He Junqin, Heeke Simon, Heymach John V

Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial.

KRYSTAL-1 试验中,Adagrasib 治疗非小细胞肺癌患者的共突变和转录特征的影响

Negrao Marcelo V, Paula Alvaro G, Molkentine David, Hover Laura, Nilsson Monique, Vokes Natalie, Engstrom Lars, Calinisan Andrew, Briere David M, Waters Laura, Hallin Jill, Diao Lixia, Altan Mehmet, Blumenschein George R, Skoulidis Ferdinandos, Wang Jing, Kopetz Scott E, Hong David S, Gibbons Don L, Olson Peter, Christensen James G, Heymach John V

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies

HER4 和 EGFR 激活 NRG1 融合驱动癌症中的细胞信号传导:对 HER2-HER3 特异性靶向与泛 HER 靶向策略的启示

Udagawa, Hibiki; Nilsson, Monique B; Robichaux, Jacqulyne P; He, Junqin; Poteete, Alissa; Jiang, Hong; Heeke, Simon; Elamin, Yasir Y; Shibata, Yuji; Matsumoto, Shingo; Yoh, Kiyotaka; Okazaki, Shogo; Masuko, Takashi; Odintsov, Igor; Somwar, Romel; Ladanyi, Marc; Goto, Koichi; Heymach, John V

Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients

3000例晚期非小细胞肺癌患者ERBB2基因改变的分子图谱

Hong, Lingzhi; Patel, Sonia; Drusbosky, Leylah M; Xiong, Yuanyuan; Chen, Rongrong; Geng, Ruixuan; Heeke, Simon; Nilsson, Monique; Wu, Jia; Heymach, John V; Wang, Yingyi; Zhang, Jianjun; Le, Xiuning

Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy

VEGF/VEGFR在癌症治疗中的分子机制及其未来意义

Patel, Sonia A; Nilsson, Monique B; Le, Xiuning; Cascone, Tina; Jain, Rakesh K; Heymach, John V

Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma

在TKI耐药的EGFR突变型肺腺癌中,化疗联合免疫疗法的获益有限

Hong, Lingzhi; Lewis, Whitney E; Nilsson, Monique; Patel, Sonia; Varghese, Susan; Rivera, Melvin J; Du, Robyn R; Chen, Pingjun; Kemp, Haley N; Rinsurongkawong, Waree; Heeke, Simon; Spelman, Amy R; Elamin, Yasir Y; Negrao, Marcelo V; Sepesi, Boris; Gibbons, Don L; Lee, J Jack; Wu, Jia; Vokes, Natalie I; Heymach, John V; Zhang, Jianjun; Le, Xiuning